|
UTP15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.18130008184426E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97019989001524E-10 |
| Normal-vs-Stage2 |
2.482900E-03 |
| Normal-vs-Stage3 |
8.23150000051065E-07 |
| Normal-vs-Stage4 |
3.42189999669174E-08 |
| Stage1-vs-Stage2 |
2.064000E-01 |
| Stage1-vs-Stage3 |
9.965200E-01 |
| Stage1-vs-Stage4 |
1.964210E-01 |
| Stage2-vs-Stage3 |
2.492000E-01 |
| Stage2-vs-Stage4 |
4.767900E-02 |
| Stage3-vs-Stage4 |
2.488600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31770003189524E-09 |
| Normal-vs-AfricanAmerican |
3.301600E-03 |
| Normal-vs-Asian |
1.11430000004908E-06 |
| Caucasian-vs-AfricanAmerican |
5.215200E-01 |
| Caucasian-vs-Asian |
7.286800E-01 |
| AfricanAmerican-vs-Asian |
3.978000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35460000386212E-08 |
| Normal-vs-Female |
4.32089997115526E-09 |
| Male-vs-Female |
3.831400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.78700001860233E-09 |
| Normal-vs-Age(41-60Yrs) |
3.45450001937309E-09 |
| Normal-vs-Age(61-80Yrs) |
2.02910000000056E-05 |
| Normal-vs-Age(81-100Yrs) |
1.267630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.161400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.248800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.340800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.257600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.185000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.803000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.761030E-01 |
| Classical-VS-Follicular |
8.927000E-01 |
| Classical-VS-Other |
9.488300E-02 |
| Classical-VS-Normal |
1.82989999819583E-08 |
| Tall-VS-Follicular |
2.440200E-01 |
| Tall-VS-Other |
2.882400E-01 |
| Tall-VS-Normal |
4.05729999997106E-06 |
| Follicular-VS-Other |
1.807440E-01 |
| Follicular-VS-Normal |
3.57750000000712E-05 |
| Other-VS-Normal |
8.368600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17729999971061E-07 |
| Normal-vs-N1 |
1.56230000047941E-07 |
| N0-vs-N1 |
2.361200E-01 |
|
|
